Infection Control News and Research

RSS

Patient experiences in hospitals declined significantly during COVID-19 pandemic

The experiences of patients hospitalized during the COVID-19 pandemic was significantly worse than in the years before the crisis, with hospitals with higher staffing levels holding on to better scores longer, according to a new RAND Corporation study.

25 Aug 2023

New recommendations to prevent catheter-associated urinary tract infections in hospitals

Avoiding the unnecessary use of indwelling catheters and promptly removing catheters that are no longer needed are the first steps in preventing catheter-associated urinary tract infections in acute care hospitals, according to new recommendations developed by five medical societies and published today in the journal Infection Control & Hospital Epidemiology.

25 Aug 2023

CPD vet webinar to highlight animal and human health collaborations improving diagnostics and therapeutics use

NORTHAMPTON, UK (15th August 2023) – HORIBA UK is to host a CPD webinar focusing on how a One Health multidisciplinary approach can enable beneficial changes in veterinary diagnostics and therapeutics usage.

From HORIBA Scientific UK 17 Aug 2023

Multimillion-dollar NIH grant awarded to develop advanced treatment for diabetic foot ulcers

A team of researchers from the Terasaki Institute for Biomedical Innovation (TIBI) and the University of Nebraska Medical Center (UNMC) has been awarded a multimillion-dollar grant from the National Institutes of Health to develop a superior, multi-pronged wound treatment for diabetic foot ulcers (DFUs).

15 Aug 2023

Study finds that nose-picking may increase COVID-19 risk in health care workers

Researchers investigated whether physical and behavioral features among healthcare workers, e.g. nose picking, could increase the risk of SARS-CoV-2 infection.

8 Aug 2023

Phage therapy shows promise in treating tough Pseudomonas aeruginosa infections

A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using phage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections, has shown promising results with an 86.6% success rate.

7 Aug 2023

Study offers new insight into how antimicrobial resistance emerges in patients with bacterial infections

A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections.

31 Jul 2023

Brazilian researchers identify new way to stop excessive inflammation in COVID-19

Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune response to SARS-CoV-2, the virus that causes the disease.

25 Jul 2023

AI and infection control: preventing infectious disease outbreaks and pandemics

Researchers discussed the role of artificial intelligence (AI) in preventing outbreaks of infectious diseases and future pandemics.

19 Jul 2023

COVID-19 vaccines saved lives of older adults with dementia in long-term care

Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, yet remained high for those living at home, according to a new study led by UC San Francisco.

17 Jul 2023

Detection of antibiotic resistance genes in clinical samples through bioinformatic approaches

Study explored the utility of metagenomic next-generation sequencing alignment methods to identify bacterial populations with antibiotic resistance.

13 Jul 2023

Study provides a transformational new insight into emergence of antimicrobial resistance

A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections.

12 Jul 2023

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Researchers identify patient groups at a higher risk of death due to COVID-19 among adults who received a second booster dose in England.

12 Jul 2023

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

7DW8-5, a glycolipid that utilizes the body's non-specific immune response to quickly combat viral infections, including COVID-19 in vivo.

11 Jul 2023

Global efforts to reduce infectious diseases must include older children and adolescents

Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.

4 Jul 2023

New photonic radar system allows highly precise and non-invasive monitoring

Constant monitoring of vital health signs is needed in a variety of clinical environments such as intensive care units, for patients with critical health conditions, health monitoring in aged care facilities and prisons, or in safety monitoring situations where drowsiness can cause accidents.

30 Jun 2023

Multi-faceted device provides rapid hemorrhage management

A multi-faceted device for effectively treating deep, non-compressible, and irregularly-shaped wounds has been engineered by the scientists at the Terasaki Institute for Biomedical Innovation (TIBI).

28 Jun 2023

Interactive dashboards improve hand hygiene compliance

Hand hygiene is the simplest, most effective way to prevent the spread of infections in healthcare, yet healthcare worker adherence is often low. Infection preventionists at two health systems will present their successful hand hygiene interventions at the Association for Professionals in Infection Control and Epidemiology's (APIC's) Annual Conference in Orlando Florida, June 26-28.

27 Jun 2023

Hospitals urged to adopt new MRSA prevention strategies

A group of five medical organizations have released updated recommendations for the prevention of methicillin-resistant Staphylococcus aureus, known as MRSA, transmission and infection. MRSA causes approximately 10% of hospital-associated infections in the United States and such infections are associated with an increased risk of death. Certain infections caused by MRSA rose by as much as 41% during the pandemic after falling in preceding years.